BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/26/2025 3:57:03 AM | Browse: 120 | Download: 254
 |
Received |
|
2025-06-07 01:45 |
|
Peer-Review Started |
|
2025-06-07 01:45 |
|
First Decision by Editorial Office Director |
|
2025-06-26 03:03 |
|
Return for Revision |
|
2025-06-26 03:03 |
|
Revised |
|
2025-07-29 15:09 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-09-29 00:38 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-10-09 08:28 |
|
Articles in Press |
|
2025-10-09 08:28 |
|
Edit the Manuscript by Language Editor |
|
2025-10-12 20:45 |
|
Typeset the Manuscript |
|
2025-11-20 02:14 |
|
Publish the Manuscript Online |
|
2025-11-26 03:57 |
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Basic Study |
| Article Title |
Cancer cell-dependent increase in senescence-like populations following exosome treatment from bone marrow and induced pluripotent stem cells-derived mesenchymal stem cells
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Nidaa A Ababneh, Sura Nashwan, Razan AlDiqs, Mohammad A Ismail, Ahmed A Abdulelah, Anas H A Abu-Humaidan, Lina AlQirem, Khairallah Al-Abdallat, Talal Al-Qaisi, Tareq Saleh and Abdalla Awidi |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Nidaa A Ababneh, Associate Professor, Cell Therapy Center, University of Jordan, Amman 11942, Jordan. n.ababneh@ju.edu.jo |
| Key Words |
Bone marrow-derived stromal cells; Induced pluripotent stem cells-derived mesenchymal stem cells; Cell-free cancer therapy; Exosomes; Breast cancer; Pancreatic cancer; Senescence-associated secretory phenotype |
| Core Tip |
This study explores the effects of exosomes (Exos) obtained from bone marrow mesenchymal stem cells (MSCs) and MSCs derived from induced pluripotent stem cells (iMSCs) on pancreatic and triple-negative breast cancer cells. iMSC-derived Exos exhibited a stronger and sustained anti-proliferative effect by inducing a senescence-like state without apoptosis. In contrast, bone marrow MSC-derived Exos showed variable effects depending on cancer type. These findings highlight the importance of Exos source in determining therapeutic outcomes and suggest senescence induction as a key response to Exos exposure. |
| Publish Date |
2025-11-26 03:57 |
| Citation |
Ababneh NA, Nashwan S, AlDiqs R, Ismail MA, Abdulelah AA, Abu-Humaidan AHA, AlQirem L, Al-Abdallat K, Al-Qaisi T, Saleh T, Awidi A. Cancer cell-dependent increase in senescence-like populations following exosome treatment from bone marrow and induced pluripotent stem cells-derived mesenchymal stem cells. World J Stem Cells 2025; 17(11): 110381 |
| URL |
https://www.wjgnet.com/1948-0210/full/v17/i11/110381.htm |
| DOI |
https://dx.doi.org/10.4252/wjsc.v17.i11.110381 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
